/ /

LATEST

Gene therapy benefits for retinal dystrophies persist through trialResults from 3 years of follow-up in the phase III trial investigating treatment with adeno-associated viral vector delivery of human RPE65 (voretigene neparvovec, Spark Therapeutics) show this gene therapy has an acceptable safety profile.
Staying calm while navigating through LASIK complicationsEncountering complications is inevitable for anyone who performs LASIK, and when the complication occurs intraoperatively, surgeons are often faced with the need to make a decision quickly, said Priyanka Sood, MD.
RLE choice factors in benefits, risks, alternativesRemoval of the crystalline lens was developed as a procedure to treat the media opacity, but advances in surgical techniques and in pseudophakic IOL technology have increased the functional use of lens-based refractive surgery, said William F. Wiley, MD.
Phase IV study shows improved DME outcomes with fluocinolone acetonide implantThe fluocinolone acetonide 0.2 mcg/day implant (Iluvien, Alimera Sciences) offers an additional option for treating diabetic macular edema that reduces the need for subsequent therapy with anti-vascular endothelial growth factor or steroid treatment.
Techniques for lacrimal canalicular lacerations steadily improving
Have we dodged another Zika bullet?Now with mosquito season past in most parts of North America, it seems we can be confident the predicted spread will not come to pass—at least in this year.
Basic estate planning protects individual and legacy
Integrating new technology into busy ophthalmic ASCAdopting new technologies across multiple practices using a single ambulatory surgery center can be challenging. A systematic approach leverages technology champions, employs consistent communications, and provides administrative support to secure reimbursement.
Investigational trials target VEGF/angiopoietin2 inhibition
Bascom Palmer takes top honors in Ophthalmology Times Best Programs SurveyAfter a seven-year hiatus, Ophthalmology Times resumed its Best Programs Survey this fall. While a few new names popped up on the list, Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine, Miami, remained at the top of the Best Overall Program category, followed again by the Wilmer Eye Institute at the Johns Hopkins University School of Medicine, Baltimore. Number three in the overall list has a new name with Dean McGee Eye Institute at the University of Oklahoma, Oklahoma City—the first time that institute has appeared in the top category since the survey’s inception 20 years ago.

Poll

View Results